Mesothelin Expression in Patients With High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome but Correlates With CD11c+ Expression in Tumor

Mesothelin Expression in Patients With High-Grade Serous Ovarian Cancer Does Not Predict Clinical Outcome but Correlates With CD11c+ Expression in Tumor

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Magalhaes, Isabelle, Fernebro, Josefin, Sulaf Abd Own, Glaessgen, Daria, Corvigno, Sara, Remberger, Mats, Mattsson, Jonas, Dahlstrand, Hanna
Format: Bild
Sprache:eng
Schlagworte:
Cancer
Cancer Diagnosis
Cancer Genetics
Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
FOS: Clinical medicine
Medicine
Obstetrics and Gynaecology
Oncology and Carcinogenesis not elsewhere classified
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.
DOI:10.6084/m9.figshare.13014242